Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

NCT01395550 · clinicaltrials.gov ↗
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca